CNS >

Herpes Simplex Encephalitis

Definition

Herpes group virus-HSV-1 causes a distinctive form of focal, necrotizing and hemorrhagic encephalitis.

Clinical Features

  • Distinctive focal, necrotizing, and hemorrhagic encephalitis
  • Annual prevalence 2–4/1,000,000
  • Leads list of potentially fatal, nonepidemic cerebral infections of viral etiology1
  • Any age
  • Often fulminant in its evolution
  • Characterized by:
    • fever
    • disordered affect
    • dysphasia
    • seizure activity
    • deterioration of consciousness

Histopathology

  • Appearances vary considerably with duration4,5
  • Earliest changes include:
    • neuronal shrinkage
    • eosinophilia
    • vascular congestion
    • spongy cortical rarefaction
    • pallor
  • Eosinophilic intranuclear inclusion bodies:
    • typical but inconstant
    • most likely seen during early symptomatic disease (Fig. 1
      HSE. As shown here, herpes simplex encephalitis may masquerade as a noninfectious, ischemic process (particularly if biopsied early in its clinical evolution). Note the noninflammatory appearance, neuronal shrinkage, pyknosis, and dissolution. The nucleus of an astrocyte in the center of this field contains a well-defined inclusion body.

      Fig. 1: HSE. As shown here, herpes simplex encephalitis may masquerade as a noninfectious, ischemic process (particularly if biopsied early in its clinical evolution). Note the noninflammatory appearance, neuronal shrinkage, pyknosis, and dissolution. The nucleus of an astrocyte in the center of this field contains a well-defined inclusion body.

      )
    • identified in nuclei of:
      • cortical astrocytes
      • satellite oligodendroglia
      • neurons
  • Pronounced inflammatory reaction:
    • characteristic of fully developed HSE
    • usually in evidence by second week of clinical disease
    • lymphocytes and plasma cells:
      • colonize meninges
      • cuff penetrating blood vessels
      • migrate into devastated cortex
    • mononuclear cells:
      • may converge on infected neurons to form neuronophagic or so-called microglial nodules
    • accompanied by:
      • hemorrhage:
        • common
      • thrombosis
        • sometimes
      • fibrinoid necrosis of cerebral vasculature:
        • sometimes
  • foamy macrophages:
    • eventually dominate invading cellular elements
      • ultimately clear necrotic debris:
        • only cavitated and gliotic remnants persist at sites of previous infection
    • Electron microscopy:
      • more laborious and less sensitive than immunocytochemistry:
        • similar appearances shared by other encephalitogenic herpes viruses
      • direct visualization of mature HSV particle in infected cells:
        • assembled in nucleus
        • an icosahedral nucleocapsid averaging 100–120nm in diameter
        • contains central density representing genomic DNA (Fig. 2
          HSE. This transmission electron photomicrograph reveals enveloped nucleocapsids with an average diameter of 100nm in the cytoplasm of an infected cell. (× 62,000).

          Fig. 2: HSE. This transmission electron photomicrograph reveals enveloped nucleocapsids with an average diameter of 100nm in the cytoplasm of an infected cell. (× 62,000).

          )
        • typically acquire lipid envelope derived from host nuclear membrane on transport into cytoplasm

Special Stains and Immunohistochemistry

  • Commercially available antibodies to HSV routinely employed
  • Immunohistochemistry strongly recommended if clinically suspected, regardless of whether histology reveals an inflammatory process (Fig. 3
    HSE. In this immunoperoxidase preparation, the cytoplasm of neurons and inclusion bodies within the nuclei of satellite glia are labeled by antibodies to herpes simplex type 1.

    Fig. 3: HSE. In this immunoperoxidase preparation, the cytoplasm of neurons and inclusion bodies within the nuclei of satellite glia are labeled by antibodies to herpes simplex type 1.

    ):
    • HSV antigen detection:
      • most likely to succeed during first week of encephalitic symptoms4
      • declines through second and third weeks coincident with mounting inflammatory reaction
      • usually not demonstrable thereafter but may be if:
        • immunocompromised, including due to cancer
        • HIV-type 1 infection3
          • appears to be arrested at noninflammatory, pseudoischemic phase characteristic of early HSE in otherwise normal individuals

Diagnosis

  • Diagnostic method of choice:
    • PCR-based amplification of HSV DNA
  • Electron microscopy and immunocytochemistry:
    • may provide evidence of HSV infection in biopsy showing little alteration at light microscopic level6

Other investigations

CSF

  • Usually pleocytosis
  • May be xanthochromia
  • PCR-based amplification of HSV DNA:
    • diagnostic method of choice
    • high degree of sensitivity and specificity1
    • HSV-specific antigens
    • genomic sequences

CT Scan or MRI

  • Abnormalities usually localized to one or both frontotemporal regions (Fig. 4
    HSE. This MRI, from a middle-aged man with headache, fever, and disordered affect, demonstrates the anteromedial temporal lobe localization of signal abnormalities (‘bright’ in this study) typical of HSE on neuroradiologic assessment.

    Fig. 4: HSE. This MRI, from a middle-aged man with headache, fever, and disordered affect, demonstrates the anteromedial temporal lobe localization of signal abnormalities (‘bright’ in this study) typical of HSE on neuroradiologic assessment.

    )

Brain Biopsy

  • Now generally obviated by assay of CSF

Differential Diagnosis

Select up to 2 differential diagnoses to compare with Herpes Simplex Encephalitis

(View full diagnosis)
(View full diagnosis)


  • Early histological changes:
    • closely mimic hypoxic-ischemic brain injury
    • may be misdiagnosed as acute cerebral infarction:
      • close scrutiny of degenerating neurons often reveals ground-glass alteration of nucleoplasm suggesting viral cytopathic effect

References

1 Whitley RJ. Herpes simplex virus.  Scheld WM,  Whitley RJ,  Durack DT editor. Infections of the central nervous system. ed. 2. Philadelphia: Lippincott-Raven; 1997.

2 Molloy S, Allcutt D, Brennan P, Farrell MA, Perryman R, Brett FM. Herpes simplex encephalitis occurring after chemotherapy, surgery, and stereotactic radiotherapy for medulloblastoma. Arch Pathol Lab Med. 2000;124:1809–1812.

3 Schiff D, Rosenblum MK. Herpes simplex encephalitis (HSE) and the immunocompromised. A clinical and autopsy study of HSE in the settings of cancer and human immunodeficiency virus-type 1 infection. Hum Pathol. 1998;29:215–222.

4 Esiri MM. Herpes simplex encephalitis. An immunohistological study of the distribution of viral antigen within the brain. J Neurol Sci. 1982;54:209–226.

5 Kennedy PG, Adams JH, Graham DI, Clements GB. A clinico-pathological study of herpes simplex encephalitis. Neuropathol Appl Neurobiol. 1988;14:395–415.

6 White CL, Taxy JB. Early morphologic diagnosis of herpes simplex virus encephalitis. Advantages of electron microscopy and immunoperoxidase staining. Hum Pathol. 1983;14:135–139.

Last updated: 30 Dec 2006

Herpes Simplex Encephalitis

Back to top